Original contributionDecreased duration of emergency department treatment of chronic obstructive pulmonary disease exacerbations with the addition of ipratropium bromide to β-agonist therapy
References (12)
Clinical pharmacology and toxicology of ipratropium bromide
Am J Med
(1986)- et al.
A comparison of the bronchodilator activity of Sch 1000 and salbutamol
J Allergy Clin Immunol
(1977) - et al.
Iprotropium bromide, salbutamol and prednisolone
Br J Dis Chest
(1978) - et al.
Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room
Am J Med
(1987) - et al.
Nebulized salbutamol with and without impratropium bromide in acute airway obstruction
Lancet
(1989) Ipratropium bromide in asthma: A review of the literature
Am J Med
(1986)
There are more references available in the full text version of this article.
Cited by (0)
This project was supported in whole or in part by BRSG 2 S07 RR 05426-27, awarded by the Biomedical Research Support Grant Program, Division of Research Resources, National Institutes of Health.
Boehringer-Ingelheim, Inc, provided the ipratropium bromide and placebo inhalers.
Copyright © 1991 Published by Mosby, Inc.